18222357

Source:http://linkedlifedata.com/resource/pubmed/id/18222357

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005330, umls-concept:C0008976, umls-concept:C0087111, umls-concept:C0231449, umls-concept:C0242339, umls-concept:C0679699, umls-concept:C1415761, umls-concept:C1522577
pubmed:issue	4
pubmed:dateCreated	2008-1-28
pubmed:abstractText	This study was designed to evaluate the long-term cardiovascular benefit of bezafibrate therapy in coronary heart disease patients enrolled in the BIP (Bezafibrate Infarction Prevention) trial.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bezafibrate, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1558-3597
pubmed:author	pubmed-author:BIP Study Group, pubmed-author:BenderlyMichalM, pubmed-author:GoldbourtUriU, pubmed-author:GoldenbergIlanI
pubmed:issnType	Electronic
pubmed:day	29
pubmed:volume	51
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	459-65
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18222357-Aged, pubmed-meshheading:18222357-Bezafibrate, pubmed-meshheading:18222357-Cholesterol, pubmed-meshheading:18222357-Double-Blind Method, pubmed-meshheading:18222357-Dyslipidemias, pubmed-meshheading:18222357-Female, pubmed-meshheading:18222357-Follow-Up Studies, pubmed-meshheading:18222357-Humans, pubmed-meshheading:18222357-Hypolipidemic Agents, pubmed-meshheading:18222357-Male, pubmed-meshheading:18222357-Middle Aged, pubmed-meshheading:18222357-Myocardial Infarction, pubmed-meshheading:18222357-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial.
pubmed:affiliation	Heart Institute, Sheba Medical Center, Tel Hashomer, Israel.
pubmed:publicationType	Journal Article, Randomized Controlled Trial